Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
This study is ongoing, but not recruiting participants.
Study NCT00057564
Information provided by Celgene Corporation
First Received: April 4, 2003
Last Updated: September 22, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
